IsoRay Announces Positive Peer Review Of Cesium-131 In Treatment Of Metastatic Brain Cancer

By: via Benzinga
IsoRay (NYSE: ISR) announced the publication of the first peer reviewed study showing the superior results from using IsoRay's ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.